Product Code:528031
Published Date: Feb 24,2023
Pages: 105
Region: Global
Category: Medical Devices & Consumables
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
SELECT A FORMAT
ADD TO BASKET
BUY NOW
Provide comprehensive and accurate analysis and reports according to your exact requirements
The global Point-of-care Testing (POCT) for Pregnancy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029. United States market for Point-of-care Testing (POCT) for Pregnancy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. China market for Point-of-care Testing (POCT) for Pregnancy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. Europe market for Point-of-care Testing (POCT) for Pregnancy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029. Global key Point-of-care Testing (POCT) for Pregnancy players cover Abbott, BioMerieux, Guangzhou Wondfo Biotech Co.,Ltd., Beijing Hotgen Biotech Co.,ltd., Assure Tech (Hangzhou) Co.,Ltd., Siemens Healthineers, Roche, Danaher and Bio-Rad Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022. LPI (LP Information)' newest research report, the “Point-of-care Testing (POCT) for Pregnancy Industry Forecast” looks at past sales and reviews total world Point-of-care Testing (POCT) for Pregnancy sales in 2022, providing a comprehensive analysis by region and market sector of projected Point-of-care Testing (POCT) for Pregnancy sales for 2023 through 2029. With Point-of-care Testing (POCT) for Pregnancy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Point-of-care Testing (POCT) for Pregnancy industry. This Insight Report provides a comprehensive analysis of the global Point-of-care Testing (POCT) for Pregnancy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Point-of-care Testing (POCT) for Pregnancy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Point-of-care Testing (POCT) for Pregnancy market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Point-of-care Testing (POCT) for Pregnancy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Point-of-care Testing (POCT) for Pregnancy. This report presents a comprehensive overview, market shares, and growth opportunities of Point-of-care Testing (POCT) for Pregnancy market by product type, application, key manufacturers and key regions and countries. Market Segmentation: Segmentation by type Based on Chemiluminescence Technology Based on Biosensor Based on Colloidal Gold Others Segmentation by application Hospital lndependent Testing Organization This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Abbott BioMerieux Guangzhou Wondfo Biotech Co.,Ltd. Beijing Hotgen Biotech Co.,ltd. Assure Tech (Hangzhou) Co.,Ltd. Siemens Healthineers Roche Danaher Bio-Rad Laboratories LifeScan J.H.Bio-Tec Key Questions Addressed in this Report What is the 10-year outlook for the global Point-of-care Testing (POCT) for Pregnancy market? What factors are driving Point-of-care Testing (POCT) for Pregnancy market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Point-of-care Testing (POCT) for Pregnancy market opportunities vary by end market size? How does Point-of-care Testing (POCT) for Pregnancy break out type, application? What are the influences of COVID-19 and Russia-Ukraine war?
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Point-of-care Testing (POCT) for Pregnancy Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Point-of-care Testing (POCT) for Pregnancy by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Point-of-care Testing (POCT) for Pregnancy by Country/Region, 2018, 2022 & 2029
2.2 Point-of-care Testing (POCT) for Pregnancy Segment by Type
2.2.1 Based on Chemiluminescence Technology
2.2.2 Based on Biosensor
2.2.3 Based on Colloidal Gold
2.2.4 Others
2.3 Point-of-care Testing (POCT) for Pregnancy Sales by Type
2.3.1 Global Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Type (2018-2023)
2.3.2 Global Point-of-care Testing (POCT) for Pregnancy Revenue and Market Share by Type (2018-2023)
2.3.3 Global Point-of-care Testing (POCT) for Pregnancy Sale Price by Type (2018-2023)
2.4 Point-of-care Testing (POCT) for Pregnancy Segment by Application
2.4.1 Hospital
2.4.2 lndependent Testing Organization
2.5 Point-of-care Testing (POCT) for Pregnancy Sales by Application
2.5.1 Global Point-of-care Testing (POCT) for Pregnancy Sale Market Share by Application (2018-2023)
2.5.2 Global Point-of-care Testing (POCT) for Pregnancy Revenue and Market Share by Application (2018-2023)
2.5.3 Global Point-of-care Testing (POCT) for Pregnancy Sale Price by Application (2018-2023)
3 Global Point-of-care Testing (POCT) for Pregnancy by Company
3.1 Global Point-of-care Testing (POCT) for Pregnancy Breakdown Data by Company
3.1.1 Global Point-of-care Testing (POCT) for Pregnancy Annual Sales by Company (2018-2023)
3.1.2 Global Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Company (2018-2023)
3.2 Global Point-of-care Testing (POCT) for Pregnancy Annual Revenue by Company (2018-2023)
3.2.1 Global Point-of-care Testing (POCT) for Pregnancy Revenue by Company (2018-2023)
3.2.2 Global Point-of-care Testing (POCT) for Pregnancy Revenue Market Share by Company (2018-2023)
3.3 Global Point-of-care Testing (POCT) for Pregnancy Sale Price by Company
3.4 Key Manufacturers Point-of-care Testing (POCT) for Pregnancy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Point-of-care Testing (POCT) for Pregnancy Product Location Distribution
3.4.2 Players Point-of-care Testing (POCT) for Pregnancy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Point-of-care Testing (POCT) for Pregnancy by Geographic Region
4.1 World Historic Point-of-care Testing (POCT) for Pregnancy Market Size by Geographic Region (2018-2023)
4.1.1 Global Point-of-care Testing (POCT) for Pregnancy Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Point-of-care Testing (POCT) for Pregnancy Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Point-of-care Testing (POCT) for Pregnancy Market Size by Country/Region (2018-2023)
4.2.1 Global Point-of-care Testing (POCT) for Pregnancy Annual Sales by Country/Region (2018-2023)
4.2.2 Global Point-of-care Testing (POCT) for Pregnancy Annual Revenue by Country/Region (2018-2023)
4.3 Americas Point-of-care Testing (POCT) for Pregnancy Sales Growth
4.4 APAC Point-of-care Testing (POCT) for Pregnancy Sales Growth
4.5 Europe Point-of-care Testing (POCT) for Pregnancy Sales Growth
4.6 Middle East & Africa Point-of-care Testing (POCT) for Pregnancy Sales Growth
5 Americas
5.1 Americas Point-of-care Testing (POCT) for Pregnancy Sales by Country
5.1.1 Americas Point-of-care Testing (POCT) for Pregnancy Sales by Country (2018-2023)
5.1.2 Americas Point-of-care Testing (POCT) for Pregnancy Revenue by Country (2018-2023)
5.2 Americas Point-of-care Testing (POCT) for Pregnancy Sales by Type
5.3 Americas Point-of-care Testing (POCT) for Pregnancy Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Point-of-care Testing (POCT) for Pregnancy Sales by Region
6.1.1 APAC Point-of-care Testing (POCT) for Pregnancy Sales by Region (2018-2023)
6.1.2 APAC Point-of-care Testing (POCT) for Pregnancy Revenue by Region (2018-2023)
6.2 APAC Point-of-care Testing (POCT) for Pregnancy Sales by Type
6.3 APAC Point-of-care Testing (POCT) for Pregnancy Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Point-of-care Testing (POCT) for Pregnancy by Country
7.1.1 Europe Point-of-care Testing (POCT) for Pregnancy Sales by Country (2018-2023)
7.1.2 Europe Point-of-care Testing (POCT) for Pregnancy Revenue by Country (2018-2023)
7.2 Europe Point-of-care Testing (POCT) for Pregnancy Sales by Type
7.3 Europe Point-of-care Testing (POCT) for Pregnancy Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Point-of-care Testing (POCT) for Pregnancy by Country
8.1.1 Middle East & Africa Point-of-care Testing (POCT) for Pregnancy Sales by Country (2018-2023)
8.1.2 Middle East & Africa Point-of-care Testing (POCT) for Pregnancy Revenue by Country (2018-2023)
8.2 Middle East & Africa Point-of-care Testing (POCT) for Pregnancy Sales by Type
8.3 Middle East & Africa Point-of-care Testing (POCT) for Pregnancy Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Pregnancy
10.3 Manufacturing Process Analysis of Point-of-care Testing (POCT) for Pregnancy
10.4 Industry Chain Structure of Point-of-care Testing (POCT) for Pregnancy
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Point-of-care Testing (POCT) for Pregnancy Distributors
11.3 Point-of-care Testing (POCT) for Pregnancy Customer
12 World Forecast Review for Point-of-care Testing (POCT) for Pregnancy by Geographic Region
12.1 Global Point-of-care Testing (POCT) for Pregnancy Market Size Forecast by Region
12.1.1 Global Point-of-care Testing (POCT) for Pregnancy Forecast by Region (2024-2029)
12.1.2 Global Point-of-care Testing (POCT) for Pregnancy Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Point-of-care Testing (POCT) for Pregnancy Forecast by Type
12.7 Global Point-of-care Testing (POCT) for Pregnancy Forecast by Application
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Point-of-care Testing (POCT) for Pregnancy Product Portfolios and Specifications
13.1.3 Abbott Point-of-care Testing (POCT) for Pregnancy Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 BioMerieux
13.2.1 BioMerieux Company Information
13.2.2 BioMerieux Point-of-care Testing (POCT) for Pregnancy Product Portfolios and Specifications
13.2.3 BioMerieux Point-of-care Testing (POCT) for Pregnancy Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BioMerieux Main Business Overview
13.2.5 BioMerieux Latest Developments
13.3 Guangzhou Wondfo Biotech Co.,Ltd.
13.3.1 Guangzhou Wondfo Biotech Co.,Ltd. Company Information
13.3.2 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Pregnancy Product Portfolios and Specifications
13.3.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Pregnancy Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Guangzhou Wondfo Biotech Co.,Ltd. Main Business Overview
13.3.5 Guangzhou Wondfo Biotech Co.,Ltd. Latest Developments
13.4 Beijing Hotgen Biotech Co.,ltd.
13.4.1 Beijing Hotgen Biotech Co.,ltd. Company Information
13.4.2 Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Pregnancy Product Portfolios and Specifications
13.4.3 Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Pregnancy Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Beijing Hotgen Biotech Co.,ltd. Main Business Overview
13.4.5 Beijing Hotgen Biotech Co.,ltd. Latest Developments
13.5 Assure Tech (Hangzhou) Co.,Ltd.
13.5.1 Assure Tech (Hangzhou) Co.,Ltd. Company Information
13.5.2 Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Pregnancy Product Portfolios and Specifications
13.5.3 Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Pregnancy Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Assure Tech (Hangzhou) Co.,Ltd. Main Business Overview
13.5.5 Assure Tech (Hangzhou) Co.,Ltd. Latest Developments
13.6 Siemens Healthineers
13.6.1 Siemens Healthineers Company Information
13.6.2 Siemens Healthineers Point-of-care Testing (POCT) for Pregnancy Product Portfolios and Specifications
13.6.3 Siemens Healthineers Point-of-care Testing (POCT) for Pregnancy Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Siemens Healthineers Main Business Overview
13.6.5 Siemens Healthineers Latest Developments
13.7 Roche
13.7.1 Roche Company Information
13.7.2 Roche Point-of-care Testing (POCT) for Pregnancy Product Portfolios and Specifications
13.7.3 Roche Point-of-care Testing (POCT) for Pregnancy Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Roche Main Business Overview
13.7.5 Roche Latest Developments
13.8 Danaher
13.8.1 Danaher Company Information
13.8.2 Danaher Point-of-care Testing (POCT) for Pregnancy Product Portfolios and Specifications
13.8.3 Danaher Point-of-care Testing (POCT) for Pregnancy Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Danaher Main Business Overview
13.8.5 Danaher Latest Developments
13.9 Bio-Rad Laboratories
13.9.1 Bio-Rad Laboratories Company Information
13.9.2 Bio-Rad Laboratories Point-of-care Testing (POCT) for Pregnancy Product Portfolios and Specifications
13.9.3 Bio-Rad Laboratories Point-of-care Testing (POCT) for Pregnancy Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Bio-Rad Laboratories Main Business Overview
13.9.5 Bio-Rad Laboratories Latest Developments
13.10 LifeScan
13.10.1 LifeScan Company Information
13.10.2 LifeScan Point-of-care Testing (POCT) for Pregnancy Product Portfolios and Specifications
13.10.3 LifeScan Point-of-care Testing (POCT) for Pregnancy Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 LifeScan Main Business Overview
13.10.5 LifeScan Latest Developments
13.11 J.H.Bio-Tec
13.11.1 J.H.Bio-Tec Company Information
13.11.2 J.H.Bio-Tec Point-of-care Testing (POCT) for Pregnancy Product Portfolios and Specifications
13.11.3 J.H.Bio-Tec Point-of-care Testing (POCT) for Pregnancy Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 J.H.Bio-Tec Main Business Overview
13.11.5 J.H.Bio-Tec Latest Developments
14 Research Findings and Conclusion
List of Tables Table 1. Point-of-care Testing (POCT) for Pregnancy Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions) Table 2. Point-of-care Testing (POCT) for Pregnancy Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions) Table 3. Major Players of Based on Chemiluminescence Technology Table 4. Major Players of Based on Biosensor Table 5. Major Players of Based on Colloidal Gold Table 6. Major Players of Others Table 7. Global Point-of-care Testing (POCT) for Pregnancy Sales by Type (2018-2023) & (K Units) Table 8. Global Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Type (2018-2023) Table 9. Global Point-of-care Testing (POCT) for Pregnancy Revenue by Type (2018-2023) & ($ million) Table 10. Global Point-of-care Testing (POCT) for Pregnancy Revenue Market Share by Type (2018-2023) Table 11. Global Point-of-care Testing (POCT) for Pregnancy Sale Price by Type (2018-2023) & (US$/Unit) Table 12. Global Point-of-care Testing (POCT) for Pregnancy Sales by Application (2018-2023) & (K Units) Table 13. Global Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Application (2018-2023) Table 14. Global Point-of-care Testing (POCT) for Pregnancy Revenue by Application (2018-2023) Table 15. Global Point-of-care Testing (POCT) for Pregnancy Revenue Market Share by Application (2018-2023) Table 16. Global Point-of-care Testing (POCT) for Pregnancy Sale Price by Application (2018-2023) & (US$/Unit) Table 17. Global Point-of-care Testing (POCT) for Pregnancy Sales by Company (2018-2023) & (K Units) Table 18. Global Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Company (2018-2023) Table 19. Global Point-of-care Testing (POCT) for Pregnancy Revenue by Company (2018-2023) ($ Millions) Table 20. Global Point-of-care Testing (POCT) for Pregnancy Revenue Market Share by Company (2018-2023) Table 21. Global Point-of-care Testing (POCT) for Pregnancy Sale Price by Company (2018-2023) & (US$/Unit) Table 22. Key Manufacturers Point-of-care Testing (POCT) for Pregnancy Producing Area Distribution and Sales Area Table 23. Players Point-of-care Testing (POCT) for Pregnancy Products Offered Table 24. Point-of-care Testing (POCT) for Pregnancy Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) Table 25. New Products and Potential Entrants Table 26. Mergers & Acquisitions, Expansion Table 27. Global Point-of-care Testing (POCT) for Pregnancy Sales by Geographic Region (2018-2023) & (K Units) Table 28. Global Point-of-care Testing (POCT) for Pregnancy Sales Market Share Geographic Region (2018-2023) Table 29. Global Point-of-care Testing (POCT) for Pregnancy Revenue by Geographic Region (2018-2023) & ($ millions) Table 30. Global Point-of-care Testing (POCT) for Pregnancy Revenue Market Share by Geographic Region (2018-2023) Table 31. Global Point-of-care Testing (POCT) for Pregnancy Sales by Country/Region (2018-2023) & (K Units) Table 32. Global Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Country/Region (2018-2023) Table 33. Global Point-of-care Testing (POCT) for Pregnancy Revenue by Country/Region (2018-2023) & ($ millions) Table 34. Global Point-of-care Testing (POCT) for Pregnancy Revenue Market Share by Country/Region (2018-2023) Table 35. Americas Point-of-care Testing (POCT) for Pregnancy Sales by Country (2018-2023) & (K Units) Table 36. Americas Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Country (2018-2023) Table 37. Americas Point-of-care Testing (POCT) for Pregnancy Revenue by Country (2018-2023) & ($ Millions) Table 38. Americas Point-of-care Testing (POCT) for Pregnancy Revenue Market Share by Country (2018-2023) Table 39. Americas Point-of-care Testing (POCT) for Pregnancy Sales by Type (2018-2023) & (K Units) Table 40. Americas Point-of-care Testing (POCT) for Pregnancy Sales by Application (2018-2023) & (K Units) Table 41. APAC Point-of-care Testing (POCT) for Pregnancy Sales by Region (2018-2023) & (K Units) Table 42. APAC Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Region (2018-2023) Table 43. APAC Point-of-care Testing (POCT) for Pregnancy Revenue by Region (2018-2023) & ($ Millions) Table 44. APAC Point-of-care Testing (POCT) for Pregnancy Revenue Market Share by Region (2018-2023) Table 45. APAC Point-of-care Testing (POCT) for Pregnancy Sales by Type (2018-2023) & (K Units) Table 46. APAC Point-of-care Testing (POCT) for Pregnancy Sales by Application (2018-2023) & (K Units) Table 47. Europe Point-of-care Testing (POCT) for Pregnancy Sales by Country (2018-2023) & (K Units) Table 48. Europe Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Country (2018-2023) Table 49. Europe Point-of-care Testing (POCT) for Pregnancy Revenue by Country (2018-2023) & ($ Millions) Table 50. Europe Point-of-care Testing (POCT) for Pregnancy Revenue Market Share by Country (2018-2023) Table 51. Europe Point-of-care Testing (POCT) for Pregnancy Sales by Type (2018-2023) & (K Units) Table 52. Europe Point-of-care Testing (POCT) for Pregnancy Sales by Application (2018-2023) & (K Units) Table 53. Middle East & Africa Point-of-care Testing (POCT) for Pregnancy Sales by Country (2018-2023) & (K Units) Table 54. Middle East & Africa Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Country (2018-2023) Table 55. Middle East & Africa Point-of-care Testing (POCT) for Pregnancy Revenue by Country (2018-2023) & ($ Millions) Table 56. Middle East & Africa Point-of-care Testing (POCT) for Pregnancy Revenue Market Share by Country (2018-2023) Table 57. Middle East & Africa Point-of-care Testing (POCT) for Pregnancy Sales by Type (2018-2023) & (K Units) Table 58. Middle East & Africa Point-of-care Testing (POCT) for Pregnancy Sales by Application (2018-2023) & (K Units) Table 59. Key Market Drivers & Growth Opportunities of Point-of-care Testing (POCT) for Pregnancy Table 60. Key Market Challenges & Risks of Point-of-care Testing (POCT) for Pregnancy Table 61. Key Industry Trends of Point-of-care Testing (POCT) for Pregnancy Table 62. Point-of-care Testing (POCT) for Pregnancy Raw Material Table 63. Key Suppliers of Raw Materials Table 64. Point-of-care Testing (POCT) for Pregnancy Distributors List Table 65. Point-of-care Testing (POCT) for Pregnancy Customer List Table 66. Global Point-of-care Testing (POCT) for Pregnancy Sales Forecast by Region (2024-2029) & (K Units) Table 67. Global Point-of-care Testing (POCT) for Pregnancy Revenue Forecast by Region (2024-2029) & ($ millions) Table 68. Americas Point-of-care Testing (POCT) for Pregnancy Sales Forecast by Country (2024-2029) & (K Units) Table 69. Americas Point-of-care Testing (POCT) for Pregnancy Revenue Forecast by Country (2024-2029) & ($ millions) Table 70. APAC Point-of-care Testing (POCT) for Pregnancy Sales Forecast by Region (2024-2029) & (K Units) Table 71. APAC Point-of-care Testing (POCT) for Pregnancy Revenue Forecast by Region (2024-2029) & ($ millions) Table 72. Europe Point-of-care Testing (POCT) for Pregnancy Sales Forecast by Country (2024-2029) & (K Units) Table 73. Europe Point-of-care Testing (POCT) for Pregnancy Revenue Forecast by Country (2024-2029) & ($ millions) Table 74. Middle East & Africa Point-of-care Testing (POCT) for Pregnancy Sales Forecast by Country (2024-2029) & (K Units) Table 75. Middle East & Africa Point-of-care Testing (POCT) for Pregnancy Revenue Forecast by Country (2024-2029) & ($ millions) Table 76. Global Point-of-care Testing (POCT) for Pregnancy Sales Forecast by Type (2024-2029) & (K Units) Table 77. Global Point-of-care Testing (POCT) for Pregnancy Revenue Forecast by Type (2024-2029) & ($ Millions) Table 78. Global Point-of-care Testing (POCT) for Pregnancy Sales Forecast by Application (2024-2029) & (K Units) Table 79. Global Point-of-care Testing (POCT) for Pregnancy Revenue Forecast by Application (2024-2029) & ($ Millions) Table 80. Abbott Basic Information, Point-of-care Testing (POCT) for Pregnancy Manufacturing Base, Sales Area and Its Competitors Table 81. Abbott Point-of-care Testing (POCT) for Pregnancy Product Portfolios and Specifications Table 82. Abbott Point-of-care Testing (POCT) for Pregnancy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 83. Abbott Main Business Table 84. Abbott Latest Developments Table 85. BioMerieux Basic Information, Point-of-care Testing (POCT) for Pregnancy Manufacturing Base, Sales Area and Its Competitors Table 86. BioMerieux Point-of-care Testing (POCT) for Pregnancy Product Portfolios and Specifications Table 87. BioMerieux Point-of-care Testing (POCT) for Pregnancy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 88. BioMerieux Main Business Table 89. BioMerieux Latest Developments Table 90. Guangzhou Wondfo Biotech Co.,Ltd. Basic Information, Point-of-care Testing (POCT) for Pregnancy Manufacturing Base, Sales Area and Its Competitors Table 91. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Pregnancy Product Portfolios and Specifications Table 92. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Pregnancy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 93. Guangzhou Wondfo Biotech Co.,Ltd. Main Business Table 94. Guangzhou Wondfo Biotech Co.,Ltd. Latest Developments Table 95. Beijing Hotgen Biotech Co.,ltd. Basic Information, Point-of-care Testing (POCT) for Pregnancy Manufacturing Base, Sales Area and Its Competitors Table 96. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Pregnancy Product Portfolios and Specifications Table 97. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Pregnancy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 98. Beijing Hotgen Biotech Co.,ltd. Main Business Table 99. Beijing Hotgen Biotech Co.,ltd. Latest Developments Table 100. Assure Tech (Hangzhou) Co.,Ltd. Basic Information, Point-of-care Testing (POCT) for Pregnancy Manufacturing Base, Sales Area and Its Competitors Table 101. Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Pregnancy Product Portfolios and Specifications Table 102. Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Pregnancy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 103. Assure Tech (Hangzhou) Co.,Ltd. Main Business Table 104. Assure Tech (Hangzhou) Co.,Ltd. Latest Developments Table 105. Siemens Healthineers Basic Information, Point-of-care Testing (POCT) for Pregnancy Manufacturing Base, Sales Area and Its Competitors Table 106. Siemens Healthineers Point-of-care Testing (POCT) for Pregnancy Product Portfolios and Specifications Table 107. Siemens Healthineers Point-of-care Testing (POCT) for Pregnancy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 108. Siemens Healthineers Main Business Table 109. Siemens Healthineers Latest Developments Table 110. Roche Basic Information, Point-of-care Testing (POCT) for Pregnancy Manufacturing Base, Sales Area and Its Competitors Table 111. Roche Point-of-care Testing (POCT) for Pregnancy Product Portfolios and Specifications Table 112. Roche Point-of-care Testing (POCT) for Pregnancy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 113. Roche Main Business Table 114. Roche Latest Developments Table 115. Danaher Basic Information, Point-of-care Testing (POCT) for Pregnancy Manufacturing Base, Sales Area and Its Competitors Table 116. Danaher Point-of-care Testing (POCT) for Pregnancy Product Portfolios and Specifications Table 117. Danaher Point-of-care Testing (POCT) for Pregnancy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 118. Danaher Main Business Table 119. Danaher Latest Developments Table 120. Bio-Rad Laboratories Basic Information, Point-of-care Testing (POCT) for Pregnancy Manufacturing Base, Sales Area and Its Competitors Table 121. Bio-Rad Laboratories Point-of-care Testing (POCT) for Pregnancy Product Portfolios and Specifications Table 122. Bio-Rad Laboratories Point-of-care Testing (POCT) for Pregnancy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 123. Bio-Rad Laboratories Main Business Table 124. Bio-Rad Laboratories Latest Developments Table 125. LifeScan Basic Information, Point-of-care Testing (POCT) for Pregnancy Manufacturing Base, Sales Area and Its Competitors Table 126. LifeScan Point-of-care Testing (POCT) for Pregnancy Product Portfolios and Specifications Table 127. LifeScan Point-of-care Testing (POCT) for Pregnancy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 128. LifeScan Main Business Table 129. LifeScan Latest Developments Table 130. J.H.Bio-Tec Basic Information, Point-of-care Testing (POCT) for Pregnancy Manufacturing Base, Sales Area and Its Competitors Table 131. J.H.Bio-Tec Point-of-care Testing (POCT) for Pregnancy Product Portfolios and Specifications Table 132. J.H.Bio-Tec Point-of-care Testing (POCT) for Pregnancy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 133. J.H.Bio-Tec Main Business Table 134. J.H.Bio-Tec Latest Developments List of Figures Figure 1. Picture of Point-of-care Testing (POCT) for Pregnancy Figure 2. Point-of-care Testing (POCT) for Pregnancy Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Point-of-care Testing (POCT) for Pregnancy Sales Growth Rate 2018-2029 (K Units) Figure 7. Global Point-of-care Testing (POCT) for Pregnancy Revenue Growth Rate 2018-2029 ($ Millions) Figure 8. Point-of-care Testing (POCT) for Pregnancy Sales by Region (2018, 2022 & 2029) & ($ Millions) Figure 9. Product Picture of Based on Chemiluminescence Technology Figure 10. Product Picture of Based on Biosensor Figure 11. Product Picture of Based on Colloidal Gold Figure 12. Product Picture of Others Figure 13. Global Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Type in 2022 Figure 14. Global Point-of-care Testing (POCT) for Pregnancy Revenue Market Share by Type (2018-2023) Figure 15. Point-of-care Testing (POCT) for Pregnancy Consumed in Hospital Figure 16. Global Point-of-care Testing (POCT) for Pregnancy Market: Hospital (2018-2023) & (K Units) Figure 17. Point-of-care Testing (POCT) for Pregnancy Consumed in lndependent Testing Organization Figure 18. Global Point-of-care Testing (POCT) for Pregnancy Market: lndependent Testing Organization (2018-2023) & (K Units) Figure 19. Global Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Application (2022) Figure 20. Global Point-of-care Testing (POCT) for Pregnancy Revenue Market Share by Application in 2022 Figure 21. Point-of-care Testing (POCT) for Pregnancy Sales Market by Company in 2022 (K Units) Figure 22. Global Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Company in 2022 Figure 23. Point-of-care Testing (POCT) for Pregnancy Revenue Market by Company in 2022 ($ Million) Figure 24. Global Point-of-care Testing (POCT) for Pregnancy Revenue Market Share by Company in 2022 Figure 25. Global Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Geographic Region (2018-2023) Figure 26. Global Point-of-care Testing (POCT) for Pregnancy Revenue Market Share by Geographic Region in 2022 Figure 27. Americas Point-of-care Testing (POCT) for Pregnancy Sales 2018-2023 (K Units) Figure 28. Americas Point-of-care Testing (POCT) for Pregnancy Revenue 2018-2023 ($ Millions) Figure 29. APAC Point-of-care Testing (POCT) for Pregnancy Sales 2018-2023 (K Units) Figure 30. APAC Point-of-care Testing (POCT) for Pregnancy Revenue 2018-2023 ($ Millions) Figure 31. Europe Point-of-care Testing (POCT) for Pregnancy Sales 2018-2023 (K Units) Figure 32. Europe Point-of-care Testing (POCT) for Pregnancy Revenue 2018-2023 ($ Millions) Figure 33. Middle East & Africa Point-of-care Testing (POCT) for Pregnancy Sales 2018-2023 (K Units) Figure 34. Middle East & Africa Point-of-care Testing (POCT) for Pregnancy Revenue 2018-2023 ($ Millions) Figure 35. Americas Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Country in 2022 Figure 36. Americas Point-of-care Testing (POCT) for Pregnancy Revenue Market Share by Country in 2022 Figure 37. Americas Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Type (2018-2023) Figure 38. Americas Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Application (2018-2023) Figure 39. United States Point-of-care Testing (POCT) for Pregnancy Revenue Growth 2018-2023 ($ Millions) Figure 40. Canada Point-of-care Testing (POCT) for Pregnancy Revenue Growth 2018-2023 ($ Millions) Figure 41. Mexico Point-of-care Testing (POCT) for Pregnancy Revenue Growth 2018-2023 ($ Millions) Figure 42. Brazil Point-of-care Testing (POCT) for Pregnancy Revenue Growth 2018-2023 ($ Millions) Figure 43. APAC Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Region in 2022 Figure 44. APAC Point-of-care Testing (POCT) for Pregnancy Revenue Market Share by Regions in 2022 Figure 45. APAC Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Type (2018-2023) Figure 46. APAC Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Application (2018-2023) Figure 47. China Point-of-care Testing (POCT) for Pregnancy Revenue Growth 2018-2023 ($ Millions) Figure 48. Japan Point-of-care Testing (POCT) for Pregnancy Revenue Growth 2018-2023 ($ Millions) Figure 49. South Korea Point-of-care Testing (POCT) for Pregnancy Revenue Growth 2018-2023 ($ Millions) Figure 50. Southeast Asia Point-of-care Testing (POCT) for Pregnancy Revenue Growth 2018-2023 ($ Millions) Figure 51. India Point-of-care Testing (POCT) for Pregnancy Revenue Growth 2018-2023 ($ Millions) Figure 52. Australia Point-of-care Testing (POCT) for Pregnancy Revenue Growth 2018-2023 ($ Millions) Figure 53. China Taiwan Point-of-care Testing (POCT) for Pregnancy Revenue Growth 2018-2023 ($ Millions) Figure 54. Europe Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Country in 2022 Figure 55. Europe Point-of-care Testing (POCT) for Pregnancy Revenue Market Share by Country in 2022 Figure 56. Europe Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Type (2018-2023) Figure 57. Europe Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Application (2018-2023) Figure 58. Germany Point-of-care Testing (POCT) for Pregnancy Revenue Growth 2018-2023 ($ Millions) Figure 59. France Point-of-care Testing (POCT) for Pregnancy Revenue Growth 2018-2023 ($ Millions) Figure 60. UK Point-of-care Testing (POCT) for Pregnancy Revenue Growth 2018-2023 ($ Millions) Figure 61. Italy Point-of-care Testing (POCT) for Pregnancy Revenue Growth 2018-2023 ($ Millions) Figure 62. Russia Point-of-care Testing (POCT) for Pregnancy Revenue Growth 2018-2023 ($ Millions) Figure 63. Middle East & Africa Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Country in 2022 Figure 64. Middle East & Africa Point-of-care Testing (POCT) for Pregnancy Revenue Market Share by Country in 2022 Figure 65. Middle East & Africa Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Type (2018-2023) Figure 66. Middle East & Africa Point-of-care Testing (POCT) for Pregnancy Sales Market Share by Application (2018-2023) Figure 67. Egypt Point-of-care Testing (POCT) for Pregnancy Revenue Growth 2018-2023 ($ Millions) Figure 68. South Africa Point-of-care Testing (POCT) for Pregnancy Revenue Growth 2018-2023 ($ Millions) Figure 69. Israel Point-of-care Testing (POCT) for Pregnancy Revenue Growth 2018-2023 ($ Millions) Figure 70. Turkey Point-of-care Testing (POCT) for Pregnancy Revenue Growth 2018-2023 ($ Millions) Figure 71. GCC Country Point-of-care Testing (POCT) for Pregnancy Revenue Growth 2018-2023 ($ Millions) Figure 72. Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Pregnancy in 2022 Figure 73. Manufacturing Process Analysis of Point-of-care Testing (POCT) for Pregnancy Figure 74. Industry Chain Structure of Point-of-care Testing (POCT) for Pregnancy Figure 75. Channels of Distribution Figure 76. Global Point-of-care Testing (POCT) for Pregnancy Sales Market Forecast by Region (2024-2029) Figure 77. Global Point-of-care Testing (POCT) for Pregnancy Revenue Market Share Forecast by Region (2024-2029) Figure 78. Global Point-of-care Testing (POCT) for Pregnancy Sales Market Share Forecast by Type (2024-2029) Figure 79. Global Point-of-care Testing (POCT) for Pregnancy Revenue Market Share Forecast by Type (2024-2029) Figure 80. Global Point-of-care Testing (POCT) for Pregnancy Sales Market Share Forecast by Application (2024-2029) Figure 81. Global Point-of-care Testing (POCT) for Pregnancy Revenue Market Share Forecast by Application (2024-2029)
Abbott BioMerieux Guangzhou Wondfo Biotech Co.,Ltd. Beijing Hotgen Biotech Co.,ltd. Assure Tech (Hangzhou) Co.,Ltd. Siemens Healthineers Roche Danaher Bio-Rad Laboratories LifeScan J.H.Bio-Tec
LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary Source
Players/Suppliers
Industry Experts
Distributors/Traders
Opinion Leaders
Front-line Staff
Marketing Executives
Secondary Source
Journals and Periodicals
Government Bodies
Annual Reports
Presentations
Paid Databases
LPI Internal Repository
Data Synthesis
Information Gathering
Collation of Data
Estimation of Key Figures
Analysis of Derived Insights
Data Validation
Triangulation with Data Models
Reference Against Proprietary
Databases
Corroboration with Industry Experts
Qualitative Analysis
Market drivers
Market challenges
Market trends
Five forces analysis
Qualitative Analysis
Market size and forecast
Market segmentation
Geographical insights
Competitive landscape